274
Views
9
CrossRef citations to date
0
Altmetric
Drug Evaluations

Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban

&
Pages 1057-1064 | Published online: 23 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Guang Jian Liu, Yun Fu Wang, Ping You Chen, Wei Chang, Ming Li Tu, Li Ying Chang, Ping Cheng & Jie Luo. (2014) The efficacy and safety of novel oral anticoagulants for the preventive treatment in atrial fibrillation patients: a systematic review and meta-analysis. Drug Delivery 21:6, pages 436-452.
Read now
Antonio Gómez-Outes, M Luisa Suárez-Gea, Ramón Lecumberri, Ana Isabel Terleira-Fernández, Emilio Vargas-Castrillón & Eduardo Rocha. (2013) Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients. Vascular Health and Risk Management 9, pages 207-228.
Read now
Gentian Denas & Vittorio Pengo. (2013) Investigational anticoagulants for hematological conditions: a new generation of therapies. Expert Opinion on Investigational Drugs 22:10, pages 1281-1294.
Read now

Articles from other publishers (6)

Siok Shen Ng, Nai Ming Lai, Surakit Nathisuwan & Nathorn Chaiyakunapruk. (2018) Interventions and Strategies to Improve Oral Anticoagulant Use in Patients with Atrial Fibrillation: A Systematic Review of Systematic Reviews. Clinical Drug Investigation 38:7, pages 579-591.
Crossref
Fen Rong, Bin Jia, Pinxian Huang, Henry S. Lynn & Wei Zhang. (2015) Safety of the direct-acting anticoagulants in patients with atrial fibrillation: a meta-analysis. Thrombosis Research 135:6, pages 1117-1123.
Crossref
Bin Jia, Henry S. Lynn, Fen Rong & Wei Zhang. (2014) Meta-analysis of Efficacy and Safety of the New Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation. Journal of Cardiovascular Pharmacology 64:4, pages 368-374.
Crossref
Jean-Pierre Bassand. (2014) Novel oral anticoagulants in acute coronary syndrome: re-evaluating the thrombin hypothesis. EuroIntervention 9:11, pages 1333-1341.
Crossref
C. G. Santos-Gallego, L. Badimon & J. J. Badimon. (2014) Perspectives: Direct and specific inhibition of factor Xa: an emerging therapeutic strategy for atherothrombotic disease. European Heart Journal Supplements 16:suppl A, pages A56-A60.
Crossref
Joey S. W. Kwong, Yat-Yin Lam, Bryan P. Yan & Cheuk-Man Yu. (2012) Bleeding of New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials. Cardiovascular Drugs and Therapy 27:1, pages 23-35.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.